Flightpath
Founded 2019 · 3 employees on LinkedIn · 3 known investors
Flightpath Biosciences develops microbiome-sparing, pathogen-specific drug candidates to treat infection-associated diseases by selectively targeting harmful bacteria while preserving healthy microbial communities. The company focuses on small molecule therapeutics for chronic and complex diseases, particularly those linked to pathogenic bacteria such as Crohn's disease.
Investors · 3
Frequently asked questions
- What does Flightpath do?
- Flightpath Biosciences develops microbiome-sparing, pathogen-specific drug candidates to treat infection-associated diseases by selectively targeting harmful bacteria while preserving healthy microbial communities. The company focuses on small molecule therapeutics for chronic and complex diseases, particularly those linked to pathogenic bacteria such as Crohn's disease.
- Who are Flightpath's investors?
- Flightpath's investors include First In Ventures, ID Ventures, Michigan Rise.